RxDoctor Payments Data

Dennis Newton, MD

Procedural Dermatology · Lewisville, TXNPI 1992747935

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $975, more than ten times the $12 reported in 2020. That places this record below the midpoint for procedural dermatology clinicians in TX, where the typical reported total is $2,420.

$2,420in general payments, 2019–2025

Across 113 payments — averaging $21.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$232
  • Regeneron Healthcare Solutions, Inc.$220
  • Amgen$213
  • AbbVie$174
  • Incyte Corporation$165
  • E.r. Squibb & Sons, L.L.C.$155
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$2,30995%
  • Education$1115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,420 in reported general payments places this provider in the 50th percentile of 25 procedural dermatology providers in Texas.

See all procedural dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$64,366
Medicare patients
295
Services billed
900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast16$76,002
Clobetasol Propionate11$354
Ketoconazole24$271
Triamcinolone Acetonide24$266
Minoxidil17$158
Fluconazole12$115
Mupirocin14$106
Doxycycline Hyclate13$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$213$76,00216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 25 procedural dermatology providers in Texas.

Other procedural dermatology in Lewisville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →